Emerging transmitted drug resistance in treatment-naïve human immunodeficiency virus-1 CRF06_cpx-infected patients in Estonia

References

• SPREAD programme. Transmission of drug-resistant HIV-1 in Europe remains limited to single classes. AIDS 2008;22:625–35.
   PubMedGoogle Scholar
• Vercauteren J, Wensing AM, van de Vijver DA, Albert J, Balotta C, Hamouda O, . Transmission of drug-resistant HIV-1 is stabilizing in Europe. J Infect Dis 2009;200:1503–8.
   PubMed Web of Science ®Google Scholar
• Yerly S, Junier T, Gayet-Ageron A, Amari EB, von Wyl V, Günthard HF, Hirschel B, Zdobnov E, Kaiser L; Swiss HIV Cohort Study. The impact of transmission clusters on primary drug resistance in newly diagnosed HIV-1 infection. AIDS 2009;23:1415–23.
   PubMed Web of Science ®Google Scholar
• Rumyantseva OA, Olkhovskiy IA, Malysheva MA, Ruzaeva LA, Vasiliev AV, Kazennova EV, . Epidemiological networks and drug resistance of HIV type 1 in Krasnoyarsk region, Russia. AIDS Res Hum Retroviruses 2009;25:931–6.
   PubMedGoogle Scholar
• Santoro MM, Ciccozzi M, Alteri C, Montieri S, Alexiev I, Dimova I, . Characterization of drug-resistance mutations in HIV type 1 isolates from drug-naïve and ARV-treated patients in Bulgaria. AIDS Res Hum Retroviruses 2008;24:1133–8.
   PubMedGoogle Scholar
• Zarandia M, Tsertsvadze T, Carr JK, Nadai Y, Sanchez JL, Nelson AK. HIV-1 genetic diversity and genotypic drug susceptibility in the Republic of Georgia. AIDS Res Hum Retroviruses 2006;22:470–6.
   PubMedGoogle Scholar
• Nabatov AA, Kravchenko ON, Lyulchuk MG, Shcherbinskaya AM, Lukashov VV. Simultaneous introduction of HIV type 1 subtype A and B viruses into injecting drug users in southern Ukraine at the beginning of the epidemic in the former Soviet Union. AIDS Res Hum Retroviruses 2002;18:891–5.
   PubMedGoogle Scholar
• Uuskula A, Kalikova A, Zilmer K, Tammai L, DeHovitz J. The role of injection drug use in the emergence of human immunodeficiency virus infection in Estonia. Int J Infect Dis 2002;6:23–7.
   PubMedGoogle Scholar
• Zetterberg V, Ustina V, Liitsola K, Zilmer K, Kalikova N, Sevastianova K, . Two viral strains and a possible novel recombinant are responsible for the explosive injecting drug use-associated HIV type 1 epidemic in Estonia. AIDS Res Hum Retroviruses 2004;20:1148–56.
   PubMed Web of Science ®Google Scholar
• Liitsola K, Holm K, Bobkov A, Pokrovsky V, Smolskaya T, Leinikki P, . An AB recombinant and its parental HIV type 1 strains in the area of the former Soviet Union: low requirements for sequence identity in recombination. UNAIDS Virus Isolation Network. AIDS Res Hum Retroviruses 2000;16:1047–53.
   PubMedGoogle Scholar
• Liitsola K, Tashkinova I, Laukkanen T, Korovina G, Smolskaja T, Momot O, . HIV-1 genetic subtype A/B recombinant strain causing an explosive epidemic in injecting drug users in Kaliningrad. AIDS 1998;12:1907–19.
   PubMed Web of Science ®Google Scholar
• Schuurman R, Nijhuis M, van Leeuwen R, Schipper P, de Jong D, Collis P, . Rapid changes in human immunodeficiency virus type 1 RNA load and appearance of drug-resistant virus populations in persons treated with lamivudine (3TC). J Infect Dis 1995;171:1411–9.
   PubMed Web of Science ®Google Scholar
• Ustina V, Zilmer K, Tammai L, Raukas M, Andersson A, Lilja E, . Epidemiology of HIV in Estonia. AIDS Res Hum Retroviruses 2001;17:81–5.
   PubMedGoogle Scholar
• Adojaan M, Kivisild T, Mannik A, Krispin T, Ustina V, Zilmer K, . Predominance of a rare type of HIV-1 in Estonia. J Acquir Immune Defic Syndr 2005;39:598–605.
   PubMedGoogle Scholar
• Avi R, Huik K, Sadam M, Karki T, Krispin T, Ainsalu K, . Absence of genotypic drug resistance and presence of several naturally occurring polymorphisms of human immunodeficiency virus-1 CRF06_cpx in treatment-naïve patients in Estonia. J Med Virol 2009;81:953–8.
   PubMedGoogle Scholar
• Tamura K, Dudley J, Nei M, Kumar S. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 2007;24:1596–9.
   PubMed Web of Science ®Google Scholar
• Liitsola K, Laukkanen T, Denisova A, Grishkevichius A, Smolskaja T, Ustina V, . Genetic characterization of HIV-1 strains in the Baltic countries and Russia. Scand J Infect Dis 1996;28:537–41.
   PubMed Web of Science ®Google Scholar
• Wensing AM, Boucher CA. Worldwide transmission of drug-resistant HIV. AIDS Rev 2003;5:140–55.
   PubMedGoogle Scholar
• Booth CL, Garcia-Diaz AM, Youle MS, Johnson MA, Phillips A, Geretti AM. Prevalence and predictors of antiretroviral drug resistance in newly diagnosed HIV-1 infection. J Antimicrob Chemother 2007;59:517–24.
   PubMedGoogle Scholar
• Hurt CB, McCoy SI, Kuruc J, Nelson JA, Kerkau M, Fiscus S, . Transmitted antiretroviral drug resistance among acute and recent HIV infections in North Carolina from 1998 to 2007. Antivir Ther 2009;14:673–8.
   PubMedGoogle Scholar
• Stanczak GP, Stanczak JJ, Marczynska M, Firlag-Burkacka E, Wiercinska-Drapalo A, Leszczyszyn-Pynka M, . Evolving patterns of HIV-1 transmitted drug resistance in Poland in the years 2000–2008. J Med Virol 2010;82:1291–4.
   PubMedGoogle Scholar
• Babic DZ, Zelnikar M, Seme K, Vandamme AM, Snoeck J, Tomazic J, . Prevalence of antiretroviral drug resistance mutations and HIV-1 non-B subtypes in newly diagnosed drug-naïve patients in Slovenia, 2000–2004. Virus Res 2006;118:156–63.
   PubMedGoogle Scholar
• Ciccozzi M, Gori C, Boros S, Ruiz-Alvarez MJ, Harxhi A, Dervishi M, . Molecular diversity of HIV in Albania. J Infect Dis 2005;192:475–9.
   PubMedGoogle Scholar
• Juhasz E, Ghidan A, Kemeny B, Nagy K. Emergence of antiretroviral drug resistance in therapy-naïve HIV infected patients in Hungary. Acta Microbiol Immunol Hung 2008;55:383–94.
   PubMedGoogle Scholar
• Kanizsai S, Ghidan A, Ujhelyi E, Banhegy D, Nagy K. Monitoring of drug resistance in therapy-naïve HIV infected patients and detection of African HIV subtypes in Hungary. Acta Microbiol Immunol Hung 2010;57:55–68.
   PubMedGoogle Scholar
• Kolupajeva T, Aldins P, Guseva L, Dusacka D, Sondore V, Viksna L, . HIV drug resistance tendencies in Latvia. Cent Eur J Public Health 2008;16:138–40.
   PubMedGoogle Scholar
• Paraschiv S, Otelea D, Dinu M, Maxim D, Tinischi M. Polymorphisms and resistance mutations in the protease and reverse transcriptase genes of HIV-1 F subtype Romanian strains. Int J Infect Dis 2007;11:123–8.
   PubMedGoogle Scholar
• Vinogradova A, Gafurova E, Munoz-Nieto M, Rakhmanova A, Osmanov S, Thomson MM. Short communication: Molecular epidemiology of HIV type 1 in the Republic of Dagestan, Russian Federation: virtually uniform circulation of subtype A, former Soviet Union variant, with predominance of the V77I(PR) subvariant. AIDS Res Hum Retroviruses 2010;26:395–400.
   PubMedGoogle Scholar
• Ferdats A, Konicheva V, Dievberna I, Lilja E, Albert J. An HIV type 1 subtype A outbreak among injecting drug users in Latvia. AIDS Res Hum Retroviruses 1999;15:1487–90.
   PubMedGoogle Scholar
• Novitsky VA, Montano MA, Essex M. Molecular epidemiology of an HIV-1 subtype A subcluster among injection drug users in the Southern Ukraine. AIDS Res Hum Retroviruses 1998;14:1079–85.
   PubMedGoogle Scholar
• Saad MD, Shcherbinskaya AM, Nadai Y, Kruglov YV, Antonenko SV, Lyullchuk MG, . Molecular epidemiology of HIV type 1 in Ukraine: birthplace of an epidemic. AIDS Res Hum Retroviruses 2006;22:709–14.
   PubMedGoogle Scholar